|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print January 22, 2002
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00442.2001
Submitted on October 4, 2001
Accepted on January 11, 2002
1 Medicine/Endocrinology, Cedars-Sinai Research Institute-UCLA School of Medicine, Los Angeles, CA, USA
* To whom correspondence should be addressed. E-mail: chesnokovav{at}cshs.org.
We have shown that leukemia inhibitory factor (LIF) and SOCS 3 are expressed in the hypothalamus and pituitary, and that LIF induces POMC and ACTH, while SOCS 3 abrogates corticotroph POMC gene transcription and ACTH secretion. Here we determined the role of pituitary LIF and SOCS 3 in regulating HPA axis inflammatory responses. Murine pituitary LIF expression was induced up to 8-fold after ip injection of LPS or TNF
, concordant with elevated plasma levels of ACTH and corticosterone. In LIF knockout mice (LIFKO), induction of both ACTH and corticosterone were attenuated. LIF deletion was associated with elevated (p<0.05) levels of pituitary TNF
, IL 1ß and IL 6 mRNA and cytokine-inducible pituitary SOCS 3 expression. Abrogation of the HPA axis stress response, and higher pituitary levels of proinflammatory cytokines observed in LIFKO mice resulted in a stronger inflammatory process as evident by elevated ESR and increased serum amyloid A levels (p<0.05). The results indicate that while LIF induces ACTH, SOCS 3 acts to counter-regulate the HPA axis response to inflammation.
This article has been cited by other articles:
![]() |
I. V Mikhaylova, T. Jaaskelainen, J. Jaaskelainen, J. J Palvimo, and R. Voutilainen Leukemia inhibitory factor as a regulator of steroidogenesis in human NCI-H295R adrenocortical cells J. Endocrinol., December 1, 2008; 199(3): 435 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gerez, J. Bonfiglio, S. Sosa, D. Giacomini, M. Acuna, A. Carbia Nagashima, M. J. Perone, S. Silberstein, U. Renner, G. K. Stalla, et al. Molecular transduction mechanisms of cytokine-hormone interactions: role of gp130 cytokines Exp Physiol, September 1, 2007; 92(5): 801 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kariagina, S. Zonis, M. Afkhami, D. Romanenko, and V. Chesnokova Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E857 - E863. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |